نتایج جستجو برای: allogeneic

تعداد نتایج: 25992  

Journal: :Aquichan 2021

Objective: To assess and correlate overall quality of life the cognitive function adult patients with hematologic cancer subjected to autologous allogeneic hematopoietic stem cell transplantations up three years after treatment. Materials method: A longitudinal, observational, analytical study was conducted 55 in a reference hospital Latin America, from September 2013 February 2019, Quality Lif...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
L Pagano M Caira A Nosari M T Van Lint A Candoni M Offidani T Aloisi G Irrera A Bonini M Picardi C Caramatti R Invernizzi D Mattei L Melillo C de Waure G Reddiconto L Fianchi C G Valentini C Girmenia G Leone F Aversa

BACKGROUND The purpose of our study was to evaluate the incidence and outcome of invasive fungal infection (IFI) among patients who underwent autologous or allogeneic hematopoietic stem cell transplantation (HSCT) at 11 Italian transplantation centers. METHODS This cohort-retrospective study, conducted during 1999-2003, involved HSCT patients admitted to 11 tertiary care centers or university...

Journal: :The Journal of Experimental Medicine 1982
SM Bradley PJ Morrissey SO Sharrow A Singer

The present study has assessed whether precursor T cells express receptors specific for the recognition of allogeneic I region-encoded determinants before their entry into the thymus. Because the ability of thymocytes to proliferate in response to allogeneic stimulator cells was shown to primarily result from the recognition of allogeneic I region determinants, thymocytes must already express a...

Journal: :Blood 1992
M A Blajchman L Bardossy R A Carmen M Goldman N M Heddle D P Singal

Approximately 50% of multi-transfused individuals become refractory to random donor platelets. Recent clinical data suggest that those patients receiving leukocyte-depleted blood products are less likely to become refractory to random donor platelets than recipients of non-leukocyte-depleted products. Leukocyte depletion can be performed immediately after collection of a unit of whole blood bef...

Journal: :Swiss medical weekly 2011
Giuseppe Vassalli Tiziano Moccetti

Over the past decade, use of autologous bone marrow-derived mononuclear cells (BMCs) has proven to be safe in phase-I/II studies in patients with myocardial infarction (MI). Taken as a whole, results support a modest yet significant improvement in cardiac function in cell-treated patients. Skeletal myoblasts, adipose-derived stem cells, and bone marrow-derived mesenchymal stem cells (MSCs) have...

Journal: :Hematology 2021

Changes in fecal microbiota affect the incidence and extent of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Most patients with hematological mal...

Journal: :Haematologica 1996
I Majolino F Aversa A Bacigalupo G Bandini W Arcese

Allogeneic transplants with PBSC are rapidly expanding, but a number of problems concerning both donors and recipients are still unsolved. GITMO (Italian Bone Marrow Transplant Group) has established a committee for allogeneic PBSC transplants. We present here an analysis of the main aspects of this evolving area and suggest revised guidelines for the use of allogeneic PBSC transplantation.

2015
Pablo Ramirez Mauricio Ocqueteau Alejandra Rodriguez Maria Jose Garcia Mauricio Sarmiento Daniel Ernst Veronica Jara Pablo Bertin

INTRODUCTION Hodgkin's lymphoma is a highly curable disease. Autologous and reduced intensity allogeneic hematopoietic cell transplantations are alternatives to treat relapsed patients. Here, we report on the results of one service using these procedures. METHODS All patients who underwent transplantations in our institution between 1996 and 2014 were retrospectively studied and demographics,...

Journal: :Cancer research 1990
N J Crowley C L Slingluff T L Darrow H F Seigler

Autologous tumor-specific cytotoxic T-lymphocytes (CTLs), generated by repeated stimulation with autologous melanoma and expanded in interleukin 2, are major histocompatibility complex restricted. These CTLs recognize a common tumor-associated antigen in the presence of HLA class I determinants, suggesting that allogeneic melanomas which express the restricting HLA-A region antigen could substi...

Journal: :Human gene therapy 2010
Matthew D Griffin Thomas Ritter Bernard P Mahon

Allogeneic mesenchymal stem or stromal cells (MSCs) are proposed as cell therapies for degenerative, inflammatory, and autoimmune diseases. The feasibility of allogeneic MSC therapies rests heavily on the concept that these cells avoid or actively suppress the immunological responses that cause rejection of most allogeneic cells and tissues. In this article the validity of the immune privileged...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید